Short answer
Prestige Consumer Healthcare Inc. (PBH) filed an 8-K current report with the SEC on June 16, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 2.03 (Creation of a Direct Financial Obligation), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). $1.045B term loan funded June 12, 2026 to finance transactions, fees, and expenses.
Prestige Consumer Healthcare Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $1.045B term loan funded June 12, 2026 to finance transactions, fees, and expenses
- Additional uncommitted borrowing capacity up to $95M for expected LaCorium Health acquisition in fiscal Q2 2027
- Interest at Term SOFR plus 2.00% or alternate base rate, with quarterly amortization of 0.25%
- Debt secured by substantially all assets, with restrictive covenants limiting acquisitions, dividends, investments, and additional debt
- ABL commitments increased to $225M and maturity extended five years, supporting liquidity and potential LaCorium funding
Item 2.01 · Completion of Acquisition or Disposition of Assets
- Completed acquisition of Breathe Right® and certain brands on June 12, 2026
- $1.045 billion cash purchase from Foundation Consumer Brands and affiliates
- Transaction expands Prestige’s consumer healthcare portfolio through MedTech subsidiary
- Material cash deployment increases scale while creating integration and execution considerations
Item 8.01 · Other Events
- Press release confirms entry into Term Loan Credit Agreement and ABL Amendment
- Completion of the Transaction marks a material financing or strategic milestone
- Investors should review Exhibit 99.1 for transaction terms, borrowing impact, and liquidity implications
Item EX-99.1 · Exhibit EX-99.1
- Acquisition closed June 15, 2026, adding Breathe Right® and other brands to Prestige’s portfolio
- Purchase price $1.045 billion, or approximately $900 million net of anticipated $150 million tax benefits
- Breathe Right becomes Prestige’s largest brand and expands the company into the nasal-strip category
- Financing comprised available cash and a new Term Loan B, increasing leverage and interest obligations
Other items in this filing:
- Item 2.03: Creation of a Direct Financial Obligation
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Prestige Consumer Healthcare Inc. 8-K filings
Get the next PBH 8-K as it lands
Follow PBH for push alerts, or ask the research agent what this filing means.